Showing 6991-7000 of 20895 results for "".
- Popular Weight-Loss Drugs Prove More Costly Than Metabolic and Bariatric Surgery Within 1 Yearhttps://reachmd.com/news/popular-weight-loss-drugs-prove-more-costly-than-metabolic-and-bariatric-surgery-within-1-year/2468465/The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) exceeds that of metabolic and bariatric surgery in less than a year, according to a
- COVID-19 Vaccination Linked to Lower Risk of Serious Cardiovascular Conditionshttps://reachmd.com/news/covid-19-vaccination-linked-to-lower-risk-of-serious-cardiovascular-conditions/2468447/A nationwide study from the University of Gothenburg reveals that full COVID-19 vaccination is associated with a significant reduction in the risk of serious cardiovascular conditions, such as heart attack, stroke, and heart failure, in those who contract COVID-19. The research also identifies a
- Validating Children's Pain May Shape Their Future Pain Managementhttps://reachmd.com/news/validating-childrens-pain-may-shape-their-future-pain-management/2468459/How parents and healthcare providers respond to a child’s pain—whether it’s a mild injury or something more serious—could have a profound impact on how that child experiences and manages pain throughout their life. A new study from the University of South Australia highlights the importance of va
- Childhood Brain Cancer Survivors at Higher Risk of Academic Setbackshttps://reachmd.com/news/childhood-brain-cancer-survivors-at-higher-risk-of-academic-setbacks/2468424/Survivors of childhood brain cancer are at a significantly higher risk of falling behind in school compared to their peers, according to a new study led by Dr. Raymond Mailhot of the University of Florida. Despite advances in treatments that increase survival rates, the academic impacts for these
- New Epinephrine Nasal Spray Approved to Combat Anaphylaxishttps://reachmd.com/news/new-epinephrine-nasal-spray-approved-to-combat-anaphylaxis/2468417/A recent approval of an epinephrine nasal spray offers patients at risk for anaphylaxis a potentially life-saving new option for treatment. While epinephrine auto-injectors have been the gold standard for managing severe allergic reactions, this new formulation could be a game-changer for those w
- Timing of Meals Linked to Lower BMI, Study Findshttps://reachmd.com/news/timing-of-meals-linked-to-lower-bmi-study-finds/2468422/A new study from the Barcelona Institute for Global Health (ISGlobal) suggests that mealtime habits, particularly extending overnight fasting and eating breakfast earlier, may play a key role in maintaining a healthy body mass index (BMI). Published in the International Journal of Behavioral
- New Protein Discovery Could Lead to Novel Osteoporosis Treatmentshttps://reachmd.com/news/new-protein-discovery-could-lead-to-novel-osteoporosis-treatments/2468426/Scientists at the University of Birmingham have identified a protein that plays a key role in preventing bone-forming cells from maturing, a discovery that could pave the way for new treatments for osteoporosis and other bone disorders. The protein, CLEC14A, is found on blood vessel cells known a
- Mavacamten Shows Promise in Reducing Cardiac Biomarkers in HFpEF Patientshttps://reachmd.com/news/mavacamten-shows-promise-in-reducing-cardiac-biomarkers-in-hfpef-patients/2468439/Mavacamten, a drug originally designed to treat hypertrophic cardiomyopathy (HCM), is showing potential for another challenging cardiac condition: heart failure with preserved ejection fraction (HFpEF). A recent study has highlighted its ability to reduce biomarkers of heart stress in HFpEF patie
- New Vial Sizes for Alzheimer's Drug Could Slash Medicare Waste and Save Millionshttps://reachmd.com/news/new-vial-sizes-for-alzheimers-drug-could-slash-medicare-waste-and-save-millions/2468414/New research indicates that Medicare could save up to $336 million annually by reducing waste from the Alzheimer’s drug lecanemab through the introduction of smaller vial sizes. The study, published in JAMA Internal Medicine, highlights how the drug’s current packaging leads to discarded
- New Blood Test Platform Validates More Than 100 Biomarkers for Alzheimer's Disease Detectionhttps://reachmd.com/news/new-blood-test-platform-validates-more-than-100-biomarkers-for-alzheimers-disease-detection/2468415/University of Pittsburgh scientists have independently validated a new blood test platform capable of measuring over 100 biomarkers related to Alzheimer’s disease. This innovative tool could revolutionize early-stage diagnostics by capturing the complex nature of Alzheimer's pathology, offering a